CGA and Alzheimer disease: Furthermore, the connection of secretory proteins with neurodegeneration, but not with amyloid plaque pathology, is consistent with recent proteomic studies in non-AD neurodegenerative diseases, such as frontotemporal dementia, where a decline of CgA, VGF and CysC occurs in the CSF of patients [84–86].